这是一篇来自已证抗体库的有关人类 CA9的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CA9 抗体。
CA9 同义词: CAIX; MN

艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 s5c
艾博抗(上海)贸易有限公司 CA9抗体(abcam, ab184006)被用于被用于免疫组化在人类样本上 (图 s5c). Oncogenesis (2021) ncbi
小鼠 单克隆(CA9/781)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 5a
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab216021)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 5a). Oncol Lett (2020) ncbi
小鼠 单克隆(2D3)
  • 免疫组化-石蜡切片; 人类; 1:80; 图 4a
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab107257)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:80 (图 4a). Oncol Rep (2020) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 3a
  • 免疫组化; 人类; 图 5a
  • 免疫印迹; 人类; 图 6d, s2c
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab184006)被用于被用于免疫细胞化学在人类样本上 (图 3a), 被用于免疫组化在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 6d, s2c). Sci Adv (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:1000; 表 3
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab128883)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (表 3). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(EPR4151(2))
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司 CA9抗体(Abcam, ab108351)被用于被用于免疫印迹在人类样本上 (图 5). J Biol Chem (2016) ncbi
Novus Biologicals
domestic rabbit 多克隆(OTI2B3)
  • 免疫组化; 人类; 图 6d
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫组化在人类样本上 (图 6d). Sci Adv (2021) ncbi
domestic rabbit 多克隆(OTI2B3)
  • 免疫印迹; 人类; 1:5000; 图 1f
Novus Biologicals CA9抗体(Novus, NB100-417)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1f). EMBO Mol Med (2018) ncbi
domestic rabbit 多克隆(OTI2B3)
  • 免疫印迹; 人类; 图 13
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫印迹在人类样本上 (图 13). PLoS ONE (2016) ncbi
domestic rabbit 多克隆(OTI2B3)
  • 免疫组化-石蜡切片; 人类; 1:2000; 图 6
Novus Biologicals CA9抗体(Novus Biologicals, #NB100?\417)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:2000 (图 6). EMBO Mol Med (2016) ncbi
domestic rabbit 多克隆(OTI2B3)
  • 免疫印迹; 人类; 1:1000; 图 4
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). J Cell Sci (2016) ncbi
domestic rabbit 多克隆(OTI2B3)
  • 免疫细胞化学; 人类; 1:500; 图 5a
  • 免疫细胞化学; 非洲爪蛙; 1:500; 图 5c
  • 免疫印迹; 非洲爪蛙; 1:500; 图 1e
Novus Biologicals CA9抗体(Novus Biologicals, NB100-417)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 5a), 被用于免疫细胞化学在非洲爪蛙样本上浓度为1:500 (图 5c) 和 被用于免疫印迹在非洲爪蛙样本上浓度为1:500 (图 1e). FEBS J (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(H-11)
  • 免疫组化; 人类; 1:100; 图 3c
圣克鲁斯生物技术 CA9抗体(Santa Cruz, sc-365900)被用于被用于免疫组化在人类样本上浓度为1:100 (图 3c). Cancer Res (2021) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:2000; 图 2a
赛默飞世尔 CA9抗体(Thermo Fisher Scientific, PA1-16592)被用于被用于免疫组化在小鼠样本上浓度为1:2000 (图 2a). Cancers (Basel) (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 s4a
赛默飞世尔 CA9抗体(Invitrogen, PA1-16592)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400 (图 s4a). J Clin Invest (2021) ncbi
小鼠 单克隆(GT12)
  • 抑制或激活实验; 人类; 图 8
  • 免疫印迹; 人类; 1:250; 图 6
赛默飞世尔 CA9抗体(Fisher Scientific, MA5-16318)被用于被用于抑制或激活实验在人类样本上 (图 8) 和 被用于免疫印迹在人类样本上浓度为1:250 (图 6). FEBS J (2016) ncbi
北京傲锐东源
小鼠 单克隆(OTI1G7)
  • 免疫组化-石蜡切片; 人类; 1:150; 图 1
北京傲锐东源 CA9抗体(Origene Technologies, OTI1G7)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (图 1). BMC Cancer (2019) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D10C10)
  • 免疫印迹; 小鼠; 图 2d
赛信通(上海)生物试剂有限公司 CA9抗体(Cell Signaling, 5648)被用于被用于免疫印迹在小鼠样本上 (图 2d). Sci Signal (2017) ncbi
domestic rabbit 单克隆(D47G3)
  • 免疫组化; 人类; 1:200
赛信通(上海)生物试剂有限公司 CA9抗体(Cell Signaling, D47G3)被用于被用于免疫组化在人类样本上浓度为1:200. Int J Clin Exp Pathol (2015) ncbi
文章列表
  1. Hoefflin R, Harlander S, Abhari B, Peighambari A, Adlesic M, Seidel P, et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13: pubmed 出版商
  2. Wang Y, Lyu Y, Tu K, Xu Q, Yang Y, Salman S, et al. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Sci Adv. 2021;7: pubmed 出版商
  3. Ashok C, Ahuja N, Natua S, Mishra J, Samaiya A, Shukla S. E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression. Oncogenesis. 2021;10:58 pubmed 出版商
  4. Nguyen Tran H, Nguyen T, Chen C, Hsu T. Endothelial Reprogramming Stimulated by Oncostatin M Promotes Inflammation and Tumorigenesis in VHL-Deficient Kidney Tissue. Cancer Res. 2021;81:5060-5073 pubmed 出版商
  5. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed 出版商
  6. Lan F, Yue X, Xia T. Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma. Oncol Lett. 2020;19:1967-1974 pubmed 出版商
  7. Chen W, Li W, Bai B, Wei H. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma. Oncol Rep. 2020;43:817-826 pubmed 出版商
  8. Li J, Shi K, Sabet Z, Fu W, Zhou H, Xu S, et al. New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy. Sci Adv. 2019;5:eaax0937 pubmed 出版商
  9. Bi C, Liu M, Rong W, Wu F, Zhang Y, Lin S, et al. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. BMC Cancer. 2019;19:213 pubmed 出版商
  10. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed 出版商
  11. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed 出版商
  12. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  13. Ono M, Yamada K, Bensaddek D, Afzal V, Biddlestone J, Ortmann B, et al. Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1α Protein Replacement Human Cell Lines. PLoS ONE. 2016;11:e0154759 pubmed 出版商
  14. Black J, Zhang H, Kim J, Getz G, Whetstine J. Regulation of Transient Site-specific Copy Gain by MicroRNA. J Biol Chem. 2016;291:4862-71 pubmed 出版商
  15. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed 出版商
  16. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed 出版商
  17. Klier M, Jamali S, Ames S, Schneider H, Becker H, Deitmer J. Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. FEBS J. 2016;283:191-200 pubmed 出版商
  18. Müller W, Schröder H, Tolba E, Diehl Seifert B, Wang X. Mineralization of bone-related SaOS-2 cells under physiological hypoxic conditions. FEBS J. 2016;283:74-87 pubmed 出版商
  19. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed